X

Vous n'êtes pas connecté

Maroc Maroc - STOCKHEAD.COM.AU - A La Une - 05/Nov 01:56

Recce Phase II clinical trial reaches key dosing milestone

A Phase II clinical trial for acute bacterial skin and skin structure infections reaches a dosing milestone. ...

Articles similaires

Recce gets nod to progress Phase 2 trial for skin infections

stockhead.com.au - 28/Oct 23:15

A key body has unanimously agreed the Phase 2 trial of Recce’s lead compound for acute bacterial skin and skin-structure ...

Sorry! Image not available at this time

ICON Plc: Clinical Trial Recruitment Representative II

pharmiweb.com - 05/Nov 00:00

Competitive: ICON Plc: Clinical Trial Recruitment Representative II ICON plc is a world-leading healthcare intelligence and clinical research...

Sorry! Image not available at this time

ICON Plc: Clinical Research Physician- Phase I Research

pharmiweb.com - 28/Oct 00:00

Competitive: ICON Plc: Clinical Research Physician II - Hungary, Budapest Office-based ICON plc is a world-leading healthcare intelligence and...

Sorry! Image not available at this time

ICON Plc: Clinical Study Manager II

pharmiweb.com - 04/Nov 00:00

Competitive: ICON Plc: Clinical Study Manager- Phase I Research ICON plc is a world-leading healthcare intelligence and clinical research...

Sorry! Image not available at this time

Repare Therapeutics reports updated positive safety and tolerability results from phase 1 MYTHIC trial

pharmabiz.com - 24/Oct 17:27

Repare Therapeutics Inc., a leading clinical─stage precision oncology company, presented updated data highlighting the benefits of its...

Sorry! Image not available at this time

Fortrea: Business Development Director (Phase II-IV) - EMEA

pharmiweb.com - 31/Oct 00:00

Competitive: Fortrea: As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical...

Sorry! Image not available at this time

Fortrea: Senior Business Development Director (Phase II-IV) - EMEA

pharmiweb.com - 02/Nov 00:00

Competitive: Fortrea: As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical...

Sorry! Image not available at this time

Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results

financialpost.com - 12:21

On track to report data from the ongoing MYTHIC dose expansion clinical trial at the recommended Phase 2 dose (RP2D) at a company event in December...

Sorry! Image not available at this time

Skin Patch Uses 'Imperceptible' Electric Zaps to Heal Wounds Without Drugs

drugs.com - 28/Oct 10:10

MONDAY, Oct. 28, 2024 -- An experimental electric bandage might help doctors stop bacterial infections without using any drugs, a new study...

Les derniers communiqués

  • Aucun élément